Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer

Presently, many studies have focused on exploring in silico approaches in the identification and development of alternative therapy for the treatment and management of cancer. Solute carrier family-2-member-4-gene (Slc2a4) which encodes glucose transporter 4 protein (GLUT4), has been identified as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aruleba, Raphael Taiwo, Adekiya, Tayo Alex, Oyinloye, Babatunji Emmanuel, Kappo, Abidemi Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855608/
https://www.ncbi.nlm.nih.gov/pubmed/29382080
http://dx.doi.org/10.3390/ijms19020386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855608/
https://www.ncbi.nlm.nih.gov/pubmed/29382080
http://dx.doi.org/10.3390/ijms19020386

Ejemplares similares